Table of contents | |
Introduction | |
Mode of Infection | |
Symptoms | |
Symptoms In Females | |
Opportunistic Infections | |
Diagnosis | |
Prevention | |
Treatment |
Once HIV enters the human body, it attaches itself to a White Blood Cell (WBC) called CD4, also called T4 cell, which are the main disease fighters of the body. Whenever there is an infection, CD4 cells lead the infection-fighting army of the body to protect it from falling sick. Hence damage of these cells can affect a person’s disease-fighting capability and general health. After making a foothold on the CD4 cell, the virus injects its RNA into the cell. The RNA then produces its DNA by using enzyme reverse transcriptase. The viral DNA then gets attached to the DNA of the host cell and thus becomes part of the cell’s genetic material.
It is a virtual takeover of the cell. Using the cell’s division mechanism, the virus now replicates and churns out hundreds of thousands of its own copies. These cells then enter the blood stream, get attached to other CD4 cells and continue to replicate. As a result the number of virus in the blood rises and CD4 cell count declines.
There are several common ways that HIV can be passed from person to person that include:
Many people do not develop any symptoms when they first become infected with HIV. Some people, however, get flu-like illness within three to six weeks after exposure to the virus. This illness, called Acute HIV Syndrome may include fever, headache, tiredness, nausea, diarrhea and enlarged lymph nodes. These symptoms usually disappear within a week to a month and are often mistaken for another viral infection. During this period, virus in the body abounds and spreads to different parts, particularly to lymphoid tissue. At this stage, the infected person is more likely to pass the infection to others.
More severe symptoms may not surface for several years, even a decade or more after the first entry of the virus or within two years in children born with the virus. Some people may begin to have symptoms as soon as a few months while others may be symptom-free for more than 10 years. During the “asymptomatic” period, the virus will be actively multiplying, infecting, and killing cells of the immune system. The following symptoms may appear in the infected person:
The number of CD4 cells per ml of blood which ranges from 500 to 1,500 in a healthy individual falls below 200 in AIDS infected people. The Viral Load will be very high at this stage. Opportunistic infections are caused by bacteria, virus, fungi and parasites. Some of the common opportunistic infections that affect HIV positive persons are: Mycobacterium avium, Tuberculosis, Salmonellosis, Bacillary Angiomatosis, Cytomegalovirus, Viral hepatitis, Herpes, Human papillomavirus, Progressive multifocal leukoencephalopathy; Candidiasis, Cryptococcal meningitis and Pneumocystis Carinii pneumonia, Toxoplasmosis, Cryptosporidiosis. HIV positive persons are also prone to cancers like Kaposi’s sarcoma and lymphoma.
Three classes of drugs are available for treatment of AIDS.
1. Nucleoside analogueReverse Transcriptase Inhibitors (NRTIs). These were first antiretroviral drugs that were developed for inhibiting the replication of HIV in the early stage by inhibiting an enzyme called Reverse Transcriptase. The drugs include Zidovudine (Retrovir, AZT), Lamivudine (Epivir, 3TC), Didanosine (Videx, ddI), Zalcitabine (Hivid, ddC), Stavudine (Zerit, d4T) and Abacavir (Ziagen).
The major reported side effect of Zidovudine is bone marrow suppression, which causes a decrease in the number of red and white blood cells. The drugs ddI, ddC and d4T can damage peripheral nerves, leading to tingling and burning sensation in hands and feet. Treatment with ddI can also cause pancreatitis, and ddC may cause mouth ulcers. Approximately 5 percent of people treated with Abacavir experience hypersensitivity with rash along with fever, fatigue, nausea, vomiting, diarrhea and abdominal pain. Symptoms usually appear within the first 6 weeks of treatment and generally disappear when the drug is discontinued.
2. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs). These drugs bind directly to the enzyme, Reverse Transcriptase. There are three NNRTIs currently approved for clinical use: Nevirapine (Viramune), Delavirdine (Rescriptor) and Efavirenz (Sustiva). A major side effect of all NNRTIS is appearance of rash. In addition, people taking Efavirenz may also have side effects such as abnormal dreams, sleeplessness, dizziness and difficulty concentrating.
3. Protease Inhibitors (PIs). They interrupt HIV replication at a later stage in its life cycle by interfering with an enzyme known as HIV protease. This causes HIV particles in the body to become structurally disorganized and noninfectious. Among these drugs are Saquinavir (Fortovase), Ritonavir (Norvir), Indinavir (Crixivan), Nelfinavir (Viracept), Amprenavir (Agenerase) and Lopinavir (Kaletra).
The triple cocktail treatment, also known as Highly Active Antiretroviral Therapy(HAART), is the closest thing that medical science has to an effective therapy, which has the ability to disrupt HIV at different stages of replication. Reverse transcriptase inhibitors, which usually make up two drugs in the HAART regimen, restrain an enzyme crucial in the early stage of HIV replication. Protease inhibitors hold back another enzyme that functions near the end of the HIV replication process.
As of now, there is no vaccine to prevent HIV infection.
181 videos|346 docs
|
1. What is the mode of infection for AIDS? |
2. What are the common symptoms of AIDS? |
3. Are the symptoms of AIDS different in females? |
4. What are opportunistic infections in AIDS patients? |
5. How is AIDS diagnosed? |
|
Explore Courses for UPSC exam
|